Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
New and emerging disease modifying therapies for multiple sclerosis.
Saidha S, Eckstein C, Calabresi PA.
Ann N Y Acad Sci. 2012 Jan;1247:117-37. doi: 10.1111/j.1749-6632.2011.06272.x. Epub 2012 Jan 6. Review.
Related citations
Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination.
Pool V, Gordon DM, Decker M.
Arch Neurol. 2012 Jan;69(1):144; author reply 144-5. No abstract available.
Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
Marcus JF, Shalev SM, Harris CA, Goodin DS, Josephson SA.
Arch Neurol. 2012 Jan;69(1):129-32.
Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.
Caramanos Z, Francis SJ, Narayanan S, Lapierre Y, Arnold DL.
Arch Neurol. 2012 Jan;69(1):89-95.
Impact of inflammation on brain volume in multiple sclerosis.
Cheriyan J, Kim S, Wolansky LJ, Cook SD, Cadavid D.
Arch Neurol. 2012 Jan;69(1):82-8.
Daclizumab use in patients with pediatric multiple sclerosis.
Gorman MP, Tillema JM, Ciliax AM, Guttmann CR, Chitnis T.
Arch Neurol. 2012 Jan;69(1):78-81.
Accurate prediction of cardiorespiratory fitness using cycle ergometry in minimally disabled persons with relapsing-remitting multiple sclerosis.
Motl RW, Fernhall B.
Arch Phys Med Rehabil. 2012 Mar;93(3):490-5. Epub 2012 Jan 5.
Therapeutic potential of carbon monoxide in multiple sclerosis.
Fagone P, Mangano K, Coco M, Perciavalle V, Garotta G, Romao CC, Nicoletti F.
Clin Exp Immunol. 2012 Feb;167(2):179-87. doi: 10.1111/j.1365-2249.2011.04491.x. Review.
Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosis.
Allali G, Laidet M, Assal F, Beauchet O, Chofflon M, Armand S, Lalive PH.
Eur Neurol. 2012;67(2):116-20. Epub 2012 Jan 10.
Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy.
Smarr CB, Hsu CL, Byrne AJ, Miller SD, Bryce PJ.
J Immunol. 2011 Nov 15;187(10):5090-8. Epub 2011 Oct 5.
Investigating channel blockers for the treatment of multiple sclerosis: considerations with mefloquine and carbenoxolone.
Nevin RL.
J Neuroimmunol. 2012 Feb 29;243(1-2):106-7. Epub 2012 Jan 10. No abstract available.
Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis.
Chen YC, Chen SD, Miao L, Liu ZG, Li W, Zhao ZX, Sun XJ, Jiang GX, Cheng Q.
J Neuroimmunol. 2012 Feb 29;243(1-2):56-60. Epub 2012 Jan 9.
Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab.
Mulero P, Caminero AB, Neri Crespo MJ, Fernández-Herranz R, Téllez Lara N.
J Neuroimmunol. 2012 Feb 29;243(1-2):103-5. Epub 2012 Jan 5.
Does fingolimod in multiple sclerosis patients cause macular edema?
Turaka K, Bryan JS.
J Neurol. 2012 Feb;259(2):386-8. Epub 2012 Jan 10.
Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
Akman-Demir G, Tüzün E, Waters P, Içöz S, Kürtüncü M, Jarius S, Yapıcı Z, Mutlu M, Yeşilot N, Vincent A, Eraksoy M.
J Neurol. 2011 Mar;258(3):464-70. Epub 2010 Oct 17.
Postural control in multiple sclerosis: effects of disability status and dual task.
Boes MK, Sosnoff JJ, Socie MJ, Sandroff BM, Pula JH, Motl RW.
J Neurol Sci. 2012 Apr 15;315(1-2):44-8. Epub 2012 Jan 10.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S.
Lancet Neurol. 2012 Feb;11(2):150-6. doi: 10.1016/S1474-4422(11)70305-2. Epub 2012 Jan 10.
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.
Miller DH, Weber T, Grove R, Wardell C, Horrigan J, Graff O, Atkinson G, Dua P, Yousry T, Macmanus D, Montalban X.
Lancet Neurol. 2012 Feb;11(2):131-9. Epub 2012 Jan 5.
Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS.
Weinstock-Guttman B, Ramanathan M.
Nat Rev Neurol. 2012 Jan 10;8(2):66-8. doi: 10.1038/nrneurol.2011.213. No abstract available.
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
Heilman KM, Williamson JB.
Neurology. 2011 Nov 29;77(22):1998-9; author reply1999-2000. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on